Literature DB >> 36271416

Association between irisin and metabolic parameters in nondiabetic, nonobese adults: a meta-analysis.

Yan Li1, Zhenbin Xu2.   

Abstract

BACKGROUND: Irisin has been proposed to have a beneficial influence on the metabolic status of animals and humans. However, the relationship between circulating irisin levels and the risks of metabolic components in humans remains unclear. In the present meta-analysis, we aimed to evaluate the association between circulating irisin and metabolic parameters in nonobese, nondiabetic adults.
METHODS: We searched PubMed, Embase, the Cochrane Library, Web of Science and ClinicalTrial.gov using the main search terms and identified original articles published prior to March 7, 2022. Studies that met our inclusion criteria and reported the association between irisin and metabolic parameters were included in our meta-analysis. We used the Newcastle Ottawa scale to assess the quality of the included studies.
RESULTS: A total of 14 studies (711 subjects) in 11 articles were included for qualitative and quantitative synthesis. The pooled results showed that circulating irisin was positively and significantly correlated with fasting blood glucose (r = 0.159), HOMA-IR (r = 0.217) and waist-to-hip ratio (WHR) (r = 0.168). However, no significant association was detected between irisin levels and other metabolic parameters.
CONCLUSIONS: Thus, these findings indicated the possible link between irisin levels and part of the metabolic parameters in apparently metabolically normal individuals. However, the regulation of irisin in metabolism in humans remains to be fully elucidated, and well-designed prospective studies will be needed in the future. Trial registration The review protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO): CRD42022315269.
© 2022. The Author(s).

Entities:  

Keywords:  Blood glucose; Insulin resistance; Irisin; Metablic syndrome; Obesity

Year:  2022        PMID: 36271416     DOI: 10.1186/s13098-022-00922-w

Source DB:  PubMed          Journal:  Diabetol Metab Syndr        ISSN: 1758-5996            Impact factor:   5.395


  49 in total

1.  Irisin: a renaissance in metabolism?

Authors:  Stergios A Polyzos; Jannis Kountouras; Kelsey Shields; Christos S Mantzoros
Journal:  Metabolism       Date:  2013-05-10       Impact factor: 8.694

2.  Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans.

Authors:  Paul Lee; Joyce D Linderman; Sheila Smith; Robert J Brychta; Juan Wang; Christopher Idelson; Rachel M Perron; Charlotte D Werner; Giao Q Phan; Udai S Kammula; Electron Kebebew; Karel Pacak; Kong Y Chen; Francesco S Celi
Journal:  Cell Metab       Date:  2014-02-04       Impact factor: 27.287

3.  Circulating irisin in relation to insulin resistance and the metabolic syndrome.

Authors:  Kyung Hee Park; Lesya Zaichenko; Mary Brinkoetter; Bindiya Thakkar; Ayse Sahin-Efe; Kyoung Eun Joung; Michael A Tsoukas; Eleni V Geladari; Joo Young Huh; Fadime Dincer; Cynthia R Davis; Judith A Crowell; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2013-09-20       Impact factor: 5.958

4.  FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.

Authors:  Joo Young Huh; Grigorios Panagiotou; Vassilis Mougios; Mary Brinkoetter; Maria T Vamvini; Benjamin E Schneider; Christos S Mantzoros
Journal:  Metabolism       Date:  2012-09-25       Impact factor: 8.694

Review 5.  Irisin as a muscle-derived hormone stimulating thermogenesis--a critical update.

Authors:  Tobias Hofmann; Ulf Elbelt; Andreas Stengel
Journal:  Peptides       Date:  2014-01-26       Impact factor: 3.750

6.  A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis.

Authors:  Pontus Boström; Jun Wu; Mark P Jedrychowski; Anisha Korde; Li Ye; James C Lo; Kyle A Rasbach; Elisabeth Almer Boström; Jang Hyun Choi; Jonathan Z Long; Shingo Kajimura; Maria Cristina Zingaretti; Birgitte F Vind; Hua Tu; Saverio Cinti; Kurt Højlund; Steven P Gygi; Bruce M Spiegelman
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

Review 7.  Metabolic syndrome: definitions and controversies.

Authors:  Eva Kassi; Panagiota Pervanidou; Gregory Kaltsas; George Chrousos
Journal:  BMC Med       Date:  2011-05-05       Impact factor: 8.775

Review 8.  Irisin: A Hope in Understanding and Managing Obesity and Metabolic Syndrome.

Authors:  Lidia I Arhire; Laura Mihalache; Mihai Covasa
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-02       Impact factor: 5.555

9.  From white to brown fat through the PGC-1α-dependent myokine irisin: implications for diabetes and obesity.

Authors:  Jorge Iván Castillo-Quan
Journal:  Dis Model Mech       Date:  2012-05       Impact factor: 5.758

Review 10.  The Global Epidemic of the Metabolic Syndrome.

Authors:  Mohammad G Saklayen
Journal:  Curr Hypertens Rep       Date:  2018-02-26       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.